The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
psilocybin. this one where in most cases, two dose treatments done in a highly clinical setting, controlled setting with patients that are carefully selected, can in many cases, the majority of people receive and maintain relief from their depressive symptoms, simply through the experience of this psychedelic journey.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
psilocybin these two sessions medically supported two sessions um has been shown to be pretty effective in the treatment of major depression not completely effective sometimes there's adverse outcomes but far more effective than the other pharmaceutical treatments that it's been compared to